【结 构 式】 |
【分子编号】21819 【品名】2-nitropropane 【CA登记号】79-46-9 |
【 分 子 式 】C3H7NO2 【 分 子 量 】89.09412 【元素组成】C 40.44% H 7.92% N 15.72% O 35.92% |
合成路线1
该中间体在本合成路线中的序号:(IV)By reaction of 3-(2-methyl-2-aminopropyl)indole (I) and 2-(2,3-epoxypropoxy)benzonitrile (II) by heating at 120-40 C followed by a treatment with HCl in ethanol. The starting products are obtained as follows: 1) The reaction of 3-(dimethylaminomethyl)indole (III) with 2-nitropropane (IV) by means of KOH gives 3-(2-methyl-2-nitropropyl)indole (V), which is then reduced with hydrazine and Raney-Ni in ethanol to yield (I). 2) The reaction of 2-hydroxybenzonitrile (VI) with epichlorohydrin (VII) by means of piperidine affords 2-(3-chloro-2-hydroxypropoxy)benzonitrile (VIII), which is epoxidized again to (II) by treatment with NaOH in hot THF-water.
【1】 Kreighbaum, W.E.; et al.; Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity. J Med Chem 1980, 23, 3, 285-289. |
【2】 Weetman, D.F.; Castaner, J.; Bucindolol Hydrochloride. Drugs Fut 1981, 6, 7, 405. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
10158 | Piperidine | 110-89-4 | C5H11N | 详情 | 详情 | |
(I) | 37566 | 2-(1H-indol-3-yl)-1,1-dimethylethylamine; 1-(1H-indol-3-yl)-2-methyl-2-propanamine | C12H16N2 | 详情 | 详情 | |
(II) | 37567 | 2-(2-oxiranylmethoxy)benzonitrile | C10H9NO2 | 详情 | 详情 | |
(III) | 37568 | N,N-Dimethyl-1H-indole-3-methanamine;Gramine;N-(1H-indol-3-ylmethyl)-N,N-dimethylamine; 3-(dimethylaminomethyl)-indole[;]1H-indol-3-yl-N,N-dimethylmethanamine | 87-52-5 | C11H14N2 | 详情 | 详情 |
(IV) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(V) | 37569 | 3-(2-methyl-2-nitropropyl)-1H-indole | C12H14N2O2 | 详情 | 详情 | |
(VI) | 21990 | 2-hydroxybenzonitrile | 611-20-1 | C7H5NO | 详情 | 详情 |
(VII) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(VIII) | 37570 | 2-(3-chloro-2-hydroxypropoxy)benzonitrile | C10H10ClNO2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Condensation of aldehyde (I) with 2-nitropropane (II) using tert-butyldimethylsilyl chloride, tetrabutylammonium fluoride and triethylamine afforded a mixture of diastereomeric nitroaldol products (III). After separation by column chromatography, the desired isomer was protected as the tert-butyldimethylsilyl ether (IV). Deprotection of the benzoate ester of (IV) was carried out by reduction with diisobutylaluminum hydride to provide alcohol (V), which was then oxidized to the corresponding ketone (VI) with pyridinium chlorochromate. Wittig reaction of (VI) with phosphorane (VII) provided the bromomethylene compound (VIII).
【1】 Oshida, J.; et al.; Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3. Bioorg Med Chem Lett 1999, 9, 3, 381. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21818 | (4S,7aR)-7a-methyl-1-[(1R)-1-methyl-4-oxobutyl]octahydro-1H-inden-4-yl benzoate | C22H30O3 | 详情 | 详情 | |
(II) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(III) | 21820 | (4S,7aR)-1-[(1R)-4-hydroxy-1,5-dimethyl-5-nitrohexyl]-7a-methyloctahydro-1H-inden-4-yl benzoate | C25H37NO5 | 详情 | 详情 | |
(IV) | 21821 | (4S,7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-yl benzoate | C31H51NO5Si | 详情 | 详情 | |
(V) | 21822 | (4S,7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-ol | C24H47NO4Si | 详情 | 详情 | |
(VI) | 21823 | (7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-4H-inden-4-one | C24H45NO4Si | 详情 | 详情 | |
(VIII) | 21824 | [[(1R,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl]oxy](tert-butyl)dimethylsilane; (1R,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl tert-butyl(dimethyl)silyl ether | C25H46BrNO3Si | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(II)Condensation of aldehyde (I) with 2-nitropropane (II) using tert-butyldimethylsilyl chloride, tetrabutylammonium fluoride and triethylamine afforded a mixture of diastereomeric nitroaldol products (III). After separation by column chromatography, the desired isomer was protected as the tert-butyldimethylsilyl ether (IV). Deprotection of the benzoate ester of (IV) was carried out by reduction with diisobutylaluminum hydride to provide alcohol (V), which was then oxidized to the corresponding ketone (VI) with pyridinium chlorochromate. Wittig reaction of (VI) with phosphorane (VII) provided the bromomethylene compound (VIII).
【1】 Oshida, J.; et al.; Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3. Bioorg Med Chem Lett 1999, 9, 3, 381. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21818 | (4S,7aR)-7a-methyl-1-[(1R)-1-methyl-4-oxobutyl]octahydro-1H-inden-4-yl benzoate | C22H30O3 | 详情 | 详情 | |
(II) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(III) | 21820 | (4S,7aR)-1-[(1R)-4-hydroxy-1,5-dimethyl-5-nitrohexyl]-7a-methyloctahydro-1H-inden-4-yl benzoate | C25H37NO5 | 详情 | 详情 | |
(IV) | 21828 | (4S,7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-yl benzoate | C31H51NO5Si | 详情 | 详情 | |
(V) | 21829 | (4S,7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-ol | C24H47NO4Si | 详情 | 详情 | |
(VI) | 21830 | (7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-4H-inden-4-one | C24H45NO4Si | 详情 | 详情 | |
(VII) | 21831 | (bromomethyl)(triphenyl)phosphonium bromide | 1034-49-7 | C19H17Br2P | 详情 | 详情 |
(VIII) | 21832 | (1S,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl tert-butyl(dimethyl)silyl ether; [[(1S,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl]oxy](tert-butyl)dimethylsilane | C25H46BrNO3Si | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(VII)NPS-2143 can be obtained by coupling 2-chloro-6-[2(R)-oxiranylmethoxy]benzonitrile (I) with 1,1-dimethyl-2-(2-naphthyl)ethylamine (II) in ethanol at 50-60 C. Intermediates (I) and (II) can be obtained as follows: a) Treatment of 2-chloro-6-fluorobenzonitrile (III) with 18-crown-6 and potassium acetate in refluxing acetonitrile, followed by hydrolysis with NaOH in H2O provides 3-chloro-2-cyanophenol (IV), which is then condensed with 3-nitrobenzenesulfonic acid (2R)-2-oxiranylmethyl ester (V) in DMF by means of NaH to furnish 2-chloro-6-[2(R)-oxiranylmethoxy]benzonitrile (I). b) Treatment of 2-(aminomethyl)naphthalene (VI) with 2,4,6-triphenylpyrylium tetrafluoroborate in EtOH, followed by the reaction of the resulting compound dissolved in DMSO with the sodium salt obtained by treatment of 2-nitropropane (VII) with NaH in MeOH, gives the nitro derivative (VIII). Finally, reduction of the nitro group of (VIII) by hydrogenation over Ni Raney in EtOH yields 1,1,-dimethyl-2-(2-naphthyl)ethylamine (II).
【2】 Sheehan, D.; Del Mar, E.G.; Lago, M.A.; Southall, L.S.; Callahan, J.F.; Kotecha, N.R.; Thompson, M.; Barmore, R.M.; Keenan, R.M.; Van Wagenen, B.C. (GlaxoSmithKline Inc.; GlaxoSmithKline plc; NPS Pharmaceuticals, Inc.); Method of using calcilytic cpds.. US 6022894 . |
【1】 del Fresno, M.; Doggrell, S.A.; Castaner, J.; NPS-2143. Drugs Fut 2002, 27, 2, 140. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
51708 | C23H17BF4O | 详情 | 详情 | |||
(I) | 51706 | 2-chloro-6-[(2R)oxiranylmethoxy]benzonitrile | C10H8ClNO2 | 详情 | 详情 | |
(II) | 51710 | 1,1-dimethyl-2-(2-naphthyl)ethylamine; 2-methyl-1-(2-naphthyl)-2-propanamine | C14H17N | 详情 | 详情 | |
(III) | 51704 | 2-Chloro-6-fluorobenzonitrile; 2-Fluoro-6-chlorobenzonitrile | 668-45-1 | C7H3ClFN | 详情 | 详情 |
(IV) | 51705 | 2-chloro-6-hydroxybenzonitrile | C7H4ClNO | 详情 | 详情 | |
(V) | 16259 | (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate | 115314-14-2 | C9H9NO6S | 详情 | 详情 |
(VI) | 51707 | 2-naphthylmethanamine; 2-naphthylmethylamine | C11H11N | 详情 | 详情 | |
(VII) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(VIII) | 51709 | 2-(2-methyl-2-nitropropyl)naphthalene | C14H15NO2 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(II)By condensation of substituted nicotinamide (VI) with the carbazolyoxymethyl-oxirane (XII) in hot methanol/water. The intermediates the nicotinamide (VI) and the oxirane (XII) have been obtained as follows: 1.- Nicotinamide (VI): The reaction of 4-hydroxybenzyl alcohol (I) with 2-nitropropane (II) by means of potassium tert-butoxide in hot diglyme gives 4-(2-methyl-2-nitropropyl)phenol (III), which is reduced to the corresponding amino derivative (IV) with H2 over Pd/C in methanol/ethanol/acetic acid. Finally, this compound is condensed with 6-chloronicotinamide (V) by means of K2CO3 in dimethylacetamide/isooctane. 2.- Oxirane (XII): The reaction of phenylhydrazine (VII) with cyclohexane-1,3-dione (VIII) by means of NaHCO3 in isopropanol/water gives the monohydrazone (IX), which is cyclized with hotpolyphosphoric acid yielding the 4-hydroxycarbazole (X). Finally, this compound is condensed with the glycidyl 3-nitrophenylsulfonate (XI) by means of K2CO3 in refluxing acetone.
【1】 Crowell, T.A.; Evrard, D.A.; Jones, C.D.; Muehl, B.S.; Rito, C.J.; Shuker, A.J.; Thorpe, A.J.; Thrasher, K.J. (Eli Lilly and Company); Carbazole analogues as selective B3 adrenergic agonists. EP 0827746; WO 9809625 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 29474 | 4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol 4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol | 623-05-2 | C7H8O2 | 详情 | 详情 |
(II) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(III) | 29475 | 4-(2-methyl-2-nitropropyl)phenol | C10H13NO3 | 详情 | 详情 | |
(IV) | 29476 | 4-(2-amino-2-methylpropyl)phenol | 51706-55-9 | C10H15NO | 详情 | 详情 |
(V) | 29477 | 6-chloronicotinamide | 6271-78-9 | C6H5ClN2O | 详情 | 详情 |
(VI) | 29478 | 6-[4-(2-amino-2-methylpropyl)phenoxy]nicotinamide | C16H19N3O2 | 详情 | 详情 | |
(VII) | 11818 | Phenyl hydrazine; 1-Phenylhydrazine | 100-63-0 | C6H8N2 | 详情 | 详情 |
(VIII) | 11244 | 1,3-Cyclohexanedione | 504-02-9 | C6H8O2 | 详情 | 详情 |
(IX) | 29479 | 3-hydroxy-2-cyclohexen-1-one N-phenylhydrazone | C12H14N2O | 详情 | 详情 | |
(X) | 29480 | 4-Hydroxycarbazole; 9H-carbazol-4-ol | 52602-39-8 | C12H9NO | 详情 | 详情 |
(XI) | 16259 | (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate | 115314-14-2 | C9H9NO6S | 详情 | 详情 |
(XII) | 29481 | 9H-carbazol-4-yl (2S)oxiranylmethyl ether; 4-[(2S)oxiranylmethoxy]-9H-carbazole | C15H13NO2 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(VI)Preparation of the title compound has been reported by two procedures. Catalytic hydrogenation of benzofuran-4-carboxylic acid (I) over Pd/C afforded the dihydrobenzofuran (II). Carboxyl group reduction in (II) with LiAlH4 and further Swern oxidation of the resulting alcohol (III) furnished aldehyde (IV). Knoevenagel condensation of aldehyde (IV) with dimethyl malonate provided the benzylidenemalonate (V), which was converted to the key cyclopropane derivative (VII) upon treatment with 2-nitropropane (VI) and potassium tert-butoxide. Hydrolysis and decarboxylation of the malonate ester (VII) was performed using NaCN in hot DMSO to yield acid (VIIIa-b) as a diastereomeric mixture. Recrystallization of (VIIIa-b) from acetonitrile-water allowed the separation of the major (+/-)-trans-isomer, which was then resolved by preparative chiral HPLC. The desired (R,R)-isomer (IX) was finally coupled with guanidine (X) via activation with CDI
【1】 Ahmad, S.; et al.; Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1. J Med Chem 2001, 44, 20, 3302. |
【2】 Wu, S.C.; Atwal, K.S.; Dugar, S.; Ahmad, S. (Bristol-Myers Squibb Co.); Acyl guanidine sodium/proton exchange inhibitors and method. EP 1041980; JP 2001527042; US 6011059; WO 9933460 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIIIa) | 51881 | (1R)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid | C14H16O3 | 详情 | 详情 | |
(VIIIb) | 51882 | (1S)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid | C14H16O3 | 详情 | 详情 | |
(I) | 51875 | 1-benzofuran-4-carboxylic acid | C9H6O3 | 详情 | 详情 | |
(II) | 51876 | 2,3-dihydro-1-benzofuran-4-carboxylic acid | C9H8O3 | 详情 | 详情 | |
(III) | 51877 | 2,3-dihydro-1-benzofuran-4-ylmethanol | C9H10O2 | 详情 | 详情 | |
(IV) | 51878 | 2,3-dihydro-1-benzofuran-4-carbaldehyde | C9H8O2 | 详情 | 详情 | |
(V) | 51879 | dimethyl 2-(2,3-dihydro-1-benzofuran-4-ylmethylene)malonate | C14H14O5 | 详情 | 详情 | |
(VI) | 21819 | 2-nitropropane | 79-46-9 | C3H7NO2 | 详情 | 详情 |
(VII) | 51880 | dimethyl 3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethyl-1,1-cyclopropanedicarboxylate | C17H20O5 | 详情 | 详情 | |
(IX) | 51883 | (1R,3R)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid | C14H16O3 | 详情 | 详情 | |
(X) | 14790 | Guanidine | 113-00-8 | CH5N3 | 详情 | 详情 |